Kymera Therapeutics, Inc. (NASDAQ:KYMR) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) have been given a consensus rating of “Moderate Buy” by the thirteen research firms that are currently covering the company, MarketBeat Ratings reports. Four analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has assigned a strong […]
More Stories
Short Interest in SWK Holdings Co. 9.00% Senior Notes due 2027 (NASDAQ:SWKHL) Drops By 84.2%
SWK Holdings Co. 9.00% Senior Notes due 2027 (NASDAQ:SWKHL – Get Free Report) was the recipient of a large decrease...
Short Interest in Starbox Group Holdings Ltd. (NASDAQ:STBX) Drops By 80.7%
Starbox Group Holdings Ltd. (NASDAQ:STBX – Get Free Report) was the target of a large drop in short interest in...
Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) Short Interest Down 98.8% in September
Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT – Get Free Report) saw a significant drop in short interest during...
Healthcare Trust, Inc. (NASDAQ:HTIA) Short Interest Up 375.0% in September
Healthcare Trust, Inc. (NASDAQ:HTIA – Get Free Report) was the target of a significant increase in short interest in September....
Short Interest in Infrax Systems, Inc. (OTCMKTS:IFXY) Increases By 253.4%
Infrax Systems, Inc. (OTCMKTS:IFXY – Get Free Report) was the target of a significant growth in short interest in the...
Short Interest in Emergent Metals Corp. (OTCMKTS:EGMCF) Grows By 411.1%
Emergent Metals Corp. (OTCMKTS:EGMCF – Get Free Report) was the recipient of a large growth in short interest in the...